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Background: A variety of severe clinical situations, such as organ failure, can determine low serum T3
state in euthyroid patients. Recently various low triiodothyronine (T3) states have been correlated with
a poor prognosis in cardiac and respiratory patients. These conditions could have an important impact
especially in hypothyroidism.
Aim: We described one case admitted to our respiratory intensive care unit (RICU) in comatose state,
suffering from acute respiratory failure due to pneumonia with untreated subclinical hypothyroidism
complicated by low T3 state.
Results: In this patient the treatment with levothyroxin alone was ineffective while replacement therapy
with synthetic sodic liothyronine proved effective and lead to clinical improvement.
Conclusion: The low T3 state is common in RICU patients and this ﬁnding could be very important in
clinical practice especially when hypothyroidism might be complicated by low T3 state. This report
suggest that in this case only the addition of T3 to T4 replacement therapy may improve clinical status.
 2009 Elsevier Ltd. All rights reserved.1. Summary
For many years, the low Triiodothyronine (T3) state has been
considered as a transient adaptive process, but there is increasing
evidence that an induced hypothyroid-like state may in it self
worsen the patient’s clinical status.1 The low T3 state is character-
ized by reduced plasma levels of T3, due to impaired activity of
speciﬁc 50 monodeiodinase converting thyroxine (T4) to T3 in
peripheral tissues.1 Circulating levels of T4 range from reduced to
slightly elevated, with either normal or slightly suppressed thyroid
stimulating hormone (TSH) levels.2
Recently various low T3 state have been correlated with
a poor prognosis in cardiac,3 burn4 and respiratory patients.5
Moreover, it has been reported that patients with hypothy-
roidism suffer signiﬁcantly more respiratory symptoms,6 and that
subjects with abnormally high levels of thyrotropine do not
experience adverse effects and may have a longer life span than
controls.7
We describe the case of a patient with previously untreated
sub-clinical hypothyroidism admitted in comatose state to our
Respiratory Intensive Care Unit for pneumonia and acute
respiratory failure. Patients improved clinical status only with: þ39 0755784260.
rved.replacement associated therapy with thyroxin and liothyronine,
because hypothyroidism was complicated by low T3 state.
2. Background
This case underlines, in our opinion, the need of considering low
T3 state as a potential cause of treatment unsuccess of hypothyroid
patients in intensive care unit.
3. Case report
An 82-year-old man with pneumonia in COPD patient was
admitted to the RICU in comatose state, and acute respiratory
failure (ARF) for invasive ventilatory support. Vital parameters and
principal laboratory data at admission are shown in Table 1.
The electrocardiograph (ECG) registration showed sinusal
bradycardia, and left anterior hemiblock; the patient also presented
transitory atrial ﬁbrillation at low cardiac rate.
A brain CT scan did not show any recent clinically signiﬁcant
focal lesions. Bilateral parenchymal opacities were seen upon chest
radiography.
Data on thyroid history before admittance to our RICU showed
non-treated sub-clinical hypothyroidism.
The study of thyroid function by direct chemiluminescence
(ADVIA centaur, Bayer Corporation, Germany) showed: TSH
41.020 UI/ml (normal range: 0.35–5.5 UI/ml), freeT3 0.77 pg/ml
Table 1
Vital parameters at admission to ICU.
Vital parameters
Arterial blood pressure (max/min.) 60/40 mmHg
Heart rate 54/min.
Respiratory rate 11/min.
Glasgow Coma Scale 7
Laboratory data
Leucocytes 6.800
Neutrophils 90.5%
BUN 119 mg/dl
Creatinine 1.76 mg/dl
Total protidemia 5.3 gr/dl
Albumine/total protidemia ratio Normal
ABG analisis (In mechanical ventilation and FiO2:40%)
pH 7.385
PaCO2 57.8 mmHg
PaO2 68,4 mmHg
HCO3 31.0 mmol/l
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0.8–1.76 ng/dl), Ab anti-thyreoglobuline <20 UI/ml (normal range
<40 UI/ml), Ab anti-TPO 65.8 UI/ml (normal value <35 UI/ml),
thyreoglobuline 137 ng/ml (normal value <55 ng/ml).
We began replacement therapy with levothyroxine 100 mcg/
die. After 10 days of therapy, the blood level of thyroidal
hormones was practically unchanged (TSH: 53.8 UI/ml; freeT3
0.56 pg/ml; freeT4 0.42 ng/dl) and the clinical condition of the
patient did not change. We then began sodic liothyronine
therapy (10 mcg 4 time/die), increasing progressively the
dosage to 20 mcg q.i.d. in addition to synthetic T4. Two days after
the beginning of liothyronine therapy thyroid function immedi-
ately improved (Fig. 1) and we observed an improvement of
respiratory rate; ABP was 135/60 mmHg, sinusal rhythm (HR 67/
min) at ECG. The TSH and freeT3 levels were 31.92 UI/ml and
3.13 pg/ml respectively.
The patient was discharged in acceptable clinical condition, in
spontaneous breathing (RR 18/min), without any ventilatory
assistance and in levothyroxine therapy at 100 mcg/die. At
discharge TSH, freeT3, and freeT4 were respectively 3.84 pg/ml,
0.66 ng/dl, and 3.374 UI/ml.pre post
timing
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Fig. 1. Improvement of thyroid function after the start of liothyronine treatment.4. Discussion
Controversy persists in the literature about the superiority of
liothyronine over levothyroxine in the treatment of thyroid disor-
ders.7 This case report provides data about the liothyronine therapy
in an area where there is not much literature.8
In our patient, with previously untreated sub-clinical hypothy-
roidism, consequent to respiratory failure due to pneumonia in
COPD patient, development of low T3 state determinesmore severe
hypothyroidism, and, the impaired activity of speciﬁc peripheral 50
monodeiodinase converting thyroxine, determines the ineffec-
tiveness of levothyroxine therapy. In addition the low levels of T4
seen during treatment, suggest deﬁcient intestinal absorption of
substitutive thyroxine therapy which improved with normalization
of serum fT3 levels.
Whereas in this case the appropriate therapy appears sodic
liothyronine combined with levothyroxine until clinical improve-
ment. Identifying low T3 state in patients with hypothyroidism is
extremely important in order to begin previously the appropriate
treatment. Indeed, the prompt identiﬁcation and treatment of this
condition can be lifesaving, may improveweaning frommechanical
ventilation and may reduce the hospital stay for intensive care unit
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